These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 21122673)
21. Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia. Huijgen R; Kindt I; Fouchier SW; Defesche JC; Hutten BA; Kastelein JJ; Vissers MN Hum Mutat; 2010 Jun; 31(6):752-60. PubMed ID: 20506408 [TBL] [Abstract][Full Text] [Related]
22. New treatments on the horizon for familial hypercholesterolemia. Allian-Sauer MU; Falko JM Expert Rev Cardiovasc Ther; 2012 Oct; 10(10):1227-37. PubMed ID: 23190063 [TBL] [Abstract][Full Text] [Related]
23. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597 [TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of mipomersen in the management of familial hypercholesterolaemia. Gelsinger C; Steinhagen-Thiessen E; Kassner U Drugs; 2012 Jul; 72(11):1445-55. PubMed ID: 22799743 [TBL] [Abstract][Full Text] [Related]
25. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
26. Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia. Streicher J; Valent P; Schmidt H; Sengölge G; Wagner O; Strobl W; Hörl WH; Derfler K J Investig Med; 1999 Sep; 47(8):378-87. PubMed ID: 10510590 [TBL] [Abstract][Full Text] [Related]
27. Lomitapide and mipomersen: novel lipid-lowering agents for the management of familial hypercholesterolemia. Dixon DL; Sisson EM; Butler M; Higbea A; Muoio B; Turner B J Cardiovasc Nurs; 2014; 29(5):E7-E12. PubMed ID: 24231894 [TBL] [Abstract][Full Text] [Related]
28. [Familial hypercholesterolemia]. Turpin G; Bruckert E Ann Med Interne (Paris); 1999 Dec; 150(8):605-14. PubMed ID: 10686642 [TBL] [Abstract][Full Text] [Related]
29. Identification of low density lipoprotein receptor abnormalities by assaying functional receptors on proliferating lymphocytes. Cuthbert JA; Lipsky PE Arteriosclerosis; 1989; 9(1 Suppl):I43-9. PubMed ID: 2912432 [TBL] [Abstract][Full Text] [Related]
30. Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemia. Gouni-Berthold I; Berthold HK Atheroscler Suppl; 2015 May; 18():28-34. PubMed ID: 25936301 [TBL] [Abstract][Full Text] [Related]
31. Mipomersen as a potential adjunctive therapy for hypercholesterolemia. Patel N; Hegele RA Expert Opin Pharmacother; 2010 Oct; 11(15):2569-72. PubMed ID: 20707601 [TBL] [Abstract][Full Text] [Related]
32. Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: report of the first case and review of the literature. Alkofer BJ; Chiche L; Khayat A; Deshayes JP; Lepage A; Saloux E; Reznik Y Transplant Proc; 2005 Jun; 37(5):2250-2. PubMed ID: 15964390 [TBL] [Abstract][Full Text] [Related]
33. Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment. Lind S; Olsson AG; Eriksson M; Rudling M; Eggertsen G; Angelin B J Intern Med; 2004 Nov; 256(5):406-12. PubMed ID: 15485476 [TBL] [Abstract][Full Text] [Related]
34. Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial. Huijgen R; Abbink EJ; Bruckert E; Stalenhoef AF; Imholz BP; Durrington PN; Trip MD; Eriksson M; Visseren FL; Schaefer JR; Kastelein JJ; Clin Ther; 2010 Apr; 32(4):615-25. PubMed ID: 20435231 [TBL] [Abstract][Full Text] [Related]
35. Novel treatments for familial hypercholesterolemia: pharmacogenetics at work. Marbach JA; McKeon JL; Ross JL; Duffy D Pharmacotherapy; 2014 Sep; 34(9):961-72. PubMed ID: 24899514 [TBL] [Abstract][Full Text] [Related]
36. JCL roundtable: drug treatment of severe forms of familial hypercholesterolemia. Brown WV; Rader DJ; Goldberg AC J Clin Lipidol; 2014; 8(1):10-7. PubMed ID: 24528683 [TBL] [Abstract][Full Text] [Related]
37. Preventing early cardiovascular death in patients with familial hypercholesterolemia. Repas TB; Tanner JR J Am Osteopath Assoc; 2014 Feb; 114(2):99-108. PubMed ID: 24481802 [TBL] [Abstract][Full Text] [Related]
38. Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal. Huijgen R; Kindt I; Verhoeven SB; Sijbrands EJ; Vissers MN; Kastelein JJ; Hutten BA PLoS One; 2010 Feb; 5(2):e9220. PubMed ID: 20169164 [TBL] [Abstract][Full Text] [Related]
39. Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes. Alonso R; Mata P; Zambón D; Mata N; Fuentes-Jiménez F Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):327-42. PubMed ID: 23469913 [TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Reeskamp LF; Kastelein JJP; Moriarty PM; Duell PB; Catapano AL; Santos RD; Ballantyne CM Atherosclerosis; 2019 Jan; 280():109-117. PubMed ID: 30500603 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]